文献速递区域麻醉与超声疼痛医学

外周与躯干神经阻滞随机试验的主要结局与预期效应量:系统范围综述

Primary outcomes and anticipated effect sizes in randomised clinical trials assessing peripheral and truncal nerve blocks: a systematic scoping review.
PubMed 文献 · Br J Anaesth · 2024-12-04

该系统范围综述检索了10本主要麻醉学期刊中关于成人手术单次超声引导外周与躯干神经阻滞的随机试验,旨在概述其报告的主要结局与预期效应量。结果显示最常报告的主要结局为术后疼痛、镇痛药用量、恢复质量、活动能力和阻滞操作表现,并汇总了各结局的中位预期效应量及样本量计算报告率。作者认为这些数据可用于未来试验以提高区域麻醉研究的同质性。

要点

  • 术后0-24小时阿片类用量中位预期效应量为9 mg静脉吗啡当量。
  • 静息和活动疼痛中位预期效应量为数字评分量表(0-10)2分。
  • 恢复质量中位预期效应量为QoR-40量表10分、QoR-15量表8分。

核心结论

  • 已发表外周与躯干神经阻滞试验的结局和效应量可用于未来试验,以提高区域麻醉研究的同质性。

研究设计与样本

  • 系统范围综述,检索Cochrane Library的CENTRAL、Medline和Embase中10本主要麻醉学期刊的英文随机试验。
  • 纳入研究为成人手术中单次超声引导外周与躯干神经阻滞的随机试验。

主要发现

  • 最常报告的主要结局为术后疼痛、镇痛药用量、恢复质量、活动能力和阻滞操作表现。
  • 中位预期效应量:0-24小时阿片类用量9 mg静脉吗啡当量;静息和活动疼痛数字评分量表(0-10)2分;恢复质量QoR-40量表10分、QoR-15量表8分。
  • 85%(156/183)的连续结局试验和91%(29/32)的二分类结局试验报告了充分的样本量计算。
  • 24%(24/99)的试验中统计学显著的主要结局未达到预期效应量,仅1项试验在结论中讨论了这一差异。

临床怎么用

  • 未来外周与躯干神经阻滞随机试验可参考本综述汇总的预期效应量进行样本量计算。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Peripheral and truncal nerve blocks provide effective analgesia facilitating perioperative care. However, thresholds for clinically relevant effects remain undetermined and are left for clinicians to choose. These choices are fundamental for sample size calculations and interpretation of study results. This systematic scoping review aimed to create an overview of primary outcomes and anticipated effect sizes in randomised clinical trials assessing peripheral and truncal nerve blocks. METHODS: We searched Cochrane Library's CENTRAL, Medline, and Embase for randomised trials in English in 10 major anaesthesia journals investigating single-injection ultrasound-guided peripheral and truncal nerve blocks for adults undergoing surgery. The primary outcome was the anticipated effect sizes for primary outcomes. Secondary outcomes included reporting of sample size calculations and statistically significant primary outcomes below anticipated effect sizes. RESULTS: The most frequently reported primary outcomes were postoperative pain, analgesic consumption, quality of recovery, mobilisation, and block performance. Median anticipated effect sizes were: 0-24 h opioid consumption: 9 mg i.v. morphine equivalents; pain at rest and during movement: 2 points on Numeric Rating Scale 0-10; quality of recovery: 10 points on Quality of Recovery-40 scale and 8 points on Quality of Recovery-15 scale. Adequate sample size calculations were reported in 85% (156/183) and 91% (29/32) of trials assessing continuous outcomes and dichotomous outcomes, respectively. Statistically significant primary outcomes failed to reach anticipated effect sizes in 24% (24/99) of trials, and only one trial addressed this disparity in the trial conclusion. CONCLUSIONS: The presented outcomes and effect sizes from published trials on peripheral and truncal nerve block literature can be used in future trials to increase homogeneity in regional anaesthesia research.

来源:Br J Anaesth,查看原文。版权归原作者所有。

引用

  1. Sorenson S, Flyger SSB, Pingel L, et al. Primary outcomes and anticipated effect sizes in randomised clinical trials assessing peripheral and truncal nerve blocks: a systematic scoping review. Br J Anaesth. 2024. PMID: 39632159. doi:10.1016/j.bja.2024.09.029

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。